Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failure
- 1 September 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 116 (3), 771-777
- https://doi.org/10.1016/0002-8703(88)90336-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Application of a frequency definition of ventricular proarrhythmiaThe American Journal of Cardiology, 1987
- Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathyThe American Journal of Cardiology, 1986
- Changes in left ventricular function during recovery from upright bicycle exercise in normal persons and patients with coronary artery diseaseThe American Journal of Cardiology, 1986
- Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failureHeart and Vessels, 1986
- Acute Hemodynamic Effects of a New Positive Inotropic Agent, 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), in Conscious and Anesthetized DogsJournal of Cardiovascular Pharmacology, 1986
- Effects of OPC-8212, a New Positive Inotropic Agent, and Dobutamine on Left Ventricular Global and Ischemic Regional Functions and Coronary Hemodynamics Under Coronary Artery StenosisJournal of Cardiovascular Pharmacology, 1986
- Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate.Circulation, 1984
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Measurement of absolute left ventricular volume from gated blood pool studies.Circulation, 1982
- Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failureThe American Journal of Cardiology, 1981